Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04150640
Title P2 5-FU, Oxaliplatin & Liposomal Irinotecan (Nal-IRI) in 1st Line Advanced Esophageal & Gastric
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison

gastroesophageal adenocarcinoma


Fluorouracil + MM-398 + Oxaliplatin

Fluorouracil + MM-398 + Oxaliplatin + Trastuzumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.